Skip to main content
Clinical Trials/IRCT20220609055116N1
IRCT20220609055116N1
Not yet recruiting
Phase 2

Clinical assessment of the efficacy of tranexamic acid-niacinamide loaded niosome in comparison to tranexamic acid-niacinamide and hydroquinone conventional creams in melasma

Shiraz University of Medical Sciences0 sites102 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Enrollment
102

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • Patients (Male/female) with melasma between 18 and 50 years old
  • Patients who have had melasma for at least 6 months ago
  • Patients who are capable to understand, read, and write the informed consent form
  • Patients who are able to participate in periodic follow\-up visits by physician

Exclusion Criteria

  • Patients who have received oral contraceptive (OCP) therapy within 3 months prior to the study initiation or during the study
  • Patients who are receiving oral corticosteroids or applying topical corticosteroids on melasma lesions during the study
  • Patients with a history of thyroid disease
  • Patients with a history of intolerance, hypersensitivity reactions, or severe irritation to hydroquinone, tranexamic acid, or niacinamide,
  • Patients with other hyperpigmentary disorders
  • Pregnancy or lactation
  • Patients who have received any pharmacologic or procedural treatment within 2 months prior to the study initiation

Investigators

Similar Trials